You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CBR

Showing 1 - 25 of 1,140
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fibromyalgia, Low Back Pain Trial in Gujar Khan (Graston Technique (Instrumented assisted soft tissue mobilization), Bowen's

Not yet recruiting
  • Fibromyalgia
  • Low Back Pain
  • Graston Technique (Instrumented assisted soft tissue mobilization)
  • Bowen's Technique(Soft tissue technique)
  • Gujar Khān, Pakistan
    Daultala centre of CBR/CBID Daultala centre of CBR/CBID and (ALP
Jul 23, 2023

Cerebral Palsy Trial in Houston (Umbilical Cord Blood Stem Cells, Saline Infusion (Placebo), Bone Marrow Stem Cells)

Completed
Has Results
  • Cerebral Palsy
  • umbilical cord blood (hUCB) cells
  • +2 more
  • Houston, Texas
    UTHealth, Medical School, Dept. of Pediatric Surgery
Oct 27, 2022

Post-Acute COVID-19 Syndrome Trial in Houston (Stem Cell)

Not yet recruiting
  • Post-Acute COVID-19 Syndrome
  • Stem Cell
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Nov 29, 2023

Surgical Procedure, Unspecified, Soft Tissue Infections, Surgical Wound Dehiscence Trial in Bologna (RPM - Osteogenics Lubbock

Active, not recruiting
  • Surgical Procedure, Unspecified
  • +5 more
  • RPM - Osteogenics Lubbock Texas USA
  • Yxoss CBR - Reoss Filderstadt Germany
  • Bologna, Italy
    School of Dentistry - University of Bologna
Dec 16, 2022

Prosthetic Joint Infection Trial in Philadelphia (TNP-2092)

Completed
  • Prosthetic Joint Infection
  • Philadelphia, Pennsylvania
    Rothman Orthopedic Institute
Oct 18, 2022

Bone Resorption Trial in Milan (Customized CAD-CAM Titanium Mesh (Y-xoss CBR® by Reoss -Filderstadt - Germany) for Guided Bone

Recruiting
  • Bone Resorption
  • Customized CAD-CAM Titanium Mesh (Y-xoss CBR® by Reoss -Filderstadt - Germany) for Guided Bone Regeneration of atrophic alveolar ridges
  • Milan, Italy
    ASST Santi Paolo e Carlo
Jul 16, 2020

Angina, Stable, CHF, COPD Trial in Pittsfield, Springfield (Stepped Care)

Recruiting
  • Angina, Stable
  • +2 more
  • Stepped Care
  • Pittsfield, Massachusetts
  • +1 more
Oct 19, 2022

Ovarian Carcinosarcoma, Uterine Carcinosarcoma Trial (Eribulin Mesylate, Pembrolizumab)

Not yet recruiting
  • Ovarian Carcinosarcoma
  • Uterine Carcinosarcoma
  • (no location specified)
Jan 31, 2023

Breast Cancer, Breast Cancer Metastatic Trial in Spain (Niraparib 100 MG, Aromatase Inhibitors)

Terminated
  • Breast Cancer
  • Breast Cancer Metastatic
  • Niraparib 100 MG
  • Aromatase Inhibitors
  • A Coruña, Spain
  • +9 more
Jan 17, 2023

Schizophrenia, Schizoaffective Disorder, Schizotypal Disorder Trial in Worldwide (SUCCEED Community-Based Intervention)

Recruiting
  • Schizophrenia
  • +10 more
  • SUCCEED Community-Based Intervention
  • Blantyre, Southern, Malawi
  • +3 more
Aug 17, 2023

Breast Cancer Trial in Spain (Olaparib)

Terminated
  • Breast Cancer
  • Barcelona, Spain
  • +7 more
Jan 18, 2023

Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in United States (NVL-655)

Recruiting
  • Locally Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Orange, California
  • +13 more
Jan 31, 2023

Prostate Cancer Metastatic, Metastasis Trial in Netherlands (Cabazitaxel, Abiraterone, Enzalutamide)

Completed
  • Prostate Cancer Metastatic
  • Metastasis
  • Alkmaar, Netherlands
  • +18 more
Apr 14, 2022

Breast Cancer Trial (Injection of A166)

Not yet recruiting
  • Breast Cancer
  • Injection of A166
  • (no location specified)
Apr 20, 2022

Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Worldwide (NVL-520)

Recruiting
  • Locally Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Orange, California
  • +18 more
Oct 6, 2022

Tanycytes in Alzheimer's Disease and Frontotemporal Dementia

Recruiting
  • Alzheimer Disease
  • Frontotemporal Dementia
  • Lumbar puncture
  • blood sample
  • Lille, France
    Memory Resources and Research Center Lille
Oct 31, 2022

Psychosis Trial in Blantyre (Enhanced Usual Care, Adapted ENHANCE Intervention)

Not yet recruiting
  • Psychosis
  • Enhanced Usual Care
  • Adapted ENHANCE Intervention
  • Blantyre, Malawi
    Queen Elizabeth Central Hosptial
Oct 16, 2023

Infections Trial in Israel, United States (E-101 Solution 300 GU/ml, Saline solution)

Completed
Has Results
  • Infections
  • E-101 Solution 300 GU/ml
  • Saline solution
  • Mobile, Alabama
  • +38 more
Jan 21, 2021

Tumor, Desmoplastic Small Round Cell, Adult, Tumor, Desmoplastic Small Round Cell, Childhood, Sarcoma, Ewing Trial in Spain (nab

Completed
  • Tumor, Desmoplastic Small Round Cell, Adult
  • +4 more
  • nab paclitaxel
  • Barcelona, Spain
  • +6 more
Jun 6, 2022

GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

Recruiting
  • GastroEsophageal Cancer
  • Gastric Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Oct 25, 2023

Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

Active, not recruiting
  • Metastatic Cancer
  • HER2 Gene Mutation
  • Neratinib Maleate
  • Seoul, Korea, Republic of
    Korea university Guro hospital
Oct 18, 2023

Triple-negative Breast Cancer Trial in Bengbu (Albumin-Bound Paclitaxel, Apatinib Mesylate, Bevacizumab)

Recruiting
  • Triple-negative Breast Cancer
  • Albumin-Bound Paclitaxel
  • +2 more
  • Bengbu, Anhui, China
    Department of Medical Oncology, First Affiliated Hospital of Ben
Mar 15, 2022

Locally Advanced or Metastatic Breast Cancer Trial in Canada, Israel, United States (Lasofoxifene, Fulvestrant)

Active, not recruiting
  • Locally Advanced or Metastatic Breast Cancer
  • Phoenix, Arizona
  • +50 more
Oct 24, 2022

Clear Cell Renal Cell Carcinoma Trial in United States (Batiraxcept, Cabozantinib (Cabo), Nivolumab)

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • Baltimore, Maryland
  • +16 more
Jan 17, 2023

Chordoma, Chemo Effect Trial in Beijing (camrelizumab and apatinib)

Recruiting
  • Chordoma
  • Chemotherapy Effect
  • camrelizumab and apatinib
  • Beijing, Beijing, China
    BEIJING
Nov 14, 2023